Literature DB >> 10329187

Cellular characterisation of p53 mutants with a single missense mutation in the beta-strand 326-333 and correlation of their cellular activities with in vitro properties.

P Chène1, E Bechter.   

Abstract

Recent evidence has shown that missense mutations in the p53 tetramerisation domain can inactivate the protein. However, most of these studies have been done only in vitro or concern proteins whose physico-chemical properties have not been fully investigated. Alanine mutants of the beta-strand 326-333 from the tetramerisation domain have been characterized in vitro and studied for their thermodynamic stability. They therefore offer a unique opportunity to establish a correlation between in vitro and cellular activities of proteins with a mutated tetramerisation domain. The eight mutant proteins resulting from the mutation of the eight residues of the beta-strand 326-333 to alanine were analysed for their ability to stimulate transcription, to inhibit the growth of Saos-2 cells and to repress the promoter of the multidrug resistance gene 1. The experimental results show a perfect correlation between in vitro and cellular data. The Leu330Ala and Ile332Ala proteins are inactive, the Phe328Ala protein has a moderate activity. The Glu326Ala, Tyr327Ala, Thr329Ala, Gln331Ala and Arg333Ala proteins show activity similar to that of wild-type protein. This work is based on an exhaustive analysis of p53 mutants both in vitro and in cells and shows that mutations in the tetramerisation domain might be of importance in cancer development since they inactivate the p53 protein. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329187     DOI: 10.1006/jmbi.1999.2738

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  5 in total

1.  Nitration of the tumor suppressor protein p53 at tyrosine 327 promotes p53 oligomerization and activation.

Authors:  Vasily A Yakovlev; Alexander S Bayden; Paul R Graves; Glen E Kellogg; Ross B Mikkelsen
Journal:  Biochemistry       Date:  2010-06-29       Impact factor: 3.162

2.  Parallel analysis of tetramerization domain mutants of the human p53 protein using PCR colonies.

Authors:  Joshua Merritt; Kim G Roberts; James A Butz; Jeremy S Edwards
Journal:  Genomic Med       Date:  2007-09-05

3.  Tetramerization-defects of p53 result in aberrant ubiquitylation and transcriptional activity.

Authors:  Valérie Lang; Chiara Pallara; Amaia Zabala; Sofia Lobato-Gil; Fernando Lopitz-Otsoa; Rosa Farrás; Roland Hjerpe; Monica Torres-Ramos; Lorea Zabaleta; Christine Blattner; Ronald T Hay; Rosa Barrio; Arkaitz Carracedo; Juan Fernandez-Recio; Manuel S Rodríguez; Fabienne Aillet
Journal:  Mol Oncol       Date:  2014-04-13       Impact factor: 6.603

4.  Noncanonical DNA motifs as transactivation targets by wild type and mutant p53.

Authors:  Jennifer J Jordan; Daniel Menendez; Alberto Inga; Maher Noureddine; Maher Nourredine; Douglas A Bell; Douglas Bell; Michael A Resnick
Journal:  PLoS Genet       Date:  2008-06-27       Impact factor: 5.917

Review 5.  p53 tetramerization: at the center of the dominant-negative effect of mutant p53.

Authors:  Jovanka Gencel-Augusto; Guillermina Lozano
Journal:  Genes Dev       Date:  2020-09-01       Impact factor: 11.361

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.